Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.
about
Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@ast
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@en
type
label
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@ast
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@en
prefLabel
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@ast
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@en
P2093
P2860
P1433
P1476
Crizotinib (PF02341066) as a A ...... utic Drug Against Lung Cancer.
@en
P2093
Cleo Rolle
Ichiro Kawada
Rajani Kanteti
Tobenna Nwizu
P2860
P356
10.1358/DOF.2011.036.02.1584112
P577
2011-02-01T00:00:00Z